Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pre-FDA approval deals

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Jun 04, 2023 12:44pm

226 Views

Post# 35479191

RE:Pre-FDA approval deals

jmm1228 wrote: Anyone have example(s) of such?

This is for the Toxic Avenger drug... 2018: Novartis will buy the Indiana-based biotech Endocyte and its experimental radiopharmaceutical drug for $2.1 billion, the Swiss pharma announced. https://www.biopharmadive.com/news/novartis-buys-endocyte-for-21b-in-latest-deal-under-ceo-narasimhan/540015/

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch